Not applicableStudy completedNCT04956198What this trial is testingDrug Sensitivity and Mutation ProfilingWho this might be right forEwing SarcomaOsteosarcomaRhabdomyosarcoma+4 more Florida International University 14
Large-scale testing (Phase 3)Study completedNCT00075582What this trial is testingVincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood Rhabdomyosarcoma+1 more Children's Oncology Group 390
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT03719430What this trial is testingAPX005M and Doxorubicin in Advanced SarcomaWho this might be right forSoft Tissue Sarcoma Alexander Z. Wei, MD 27
Not applicableStudy completedNCT02986503What this trial is testingEuropean Study in Bone Sarcoma Patients Over 40 YearsWho this might be right forSpindle Cell Sarcoma of BoneOsteosarcoma Italian Sarcoma Group 100
Not applicableNo Longer AvailableNCT03874455What this trial is testingTazemetostat Expanded Access Program for Adults With Solid TumorsWho this might be right forEpithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more Epizyme, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT04994132What this trial is testingCompare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaWho this might be right forAlveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+5 more Children's Oncology Group 118
Testing effectiveness (Phase 2)Study completedNCT00661609What this trial is testingA Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more AstraZeneca 54
Testing effectiveness (Phase 2)Looking for participantsNCT06239272What this trial is testingNRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)Who this might be right forAdipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6 more St. Jude Children's Research Hospital 139
Early research (Phase 1)Study completedNCT01248923What this trial is testingARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma, Plasma Cell Leukemia Array Biopharma, now a wholly owned subsidiary of Pfizer 55
Not applicableAvailableNCT05974410What this trial is testingExpanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsWho this might be right forGlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more AVM Biotechnology Inc
Testing effectiveness (Phase 2)Ended earlyNCT02022358What this trial is testingWill Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?Who this might be right forOsteosarcomaSpindle Cell Sarcoma of Bone University College, London 34
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Large-scale testing (Phase 3)Temporarily pausedNCT06568172What this trial is testingTesting the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin CancerWho this might be right forEyelid Squamous Cell CarcinomaRecurrent Eyelid Squamous Cell CarcinomaRecurrent Skin Acantholytic Squamous Cell Carcinoma+17 more National Cancer Institute (NCI) 420
Large-scale testing (Phase 3)Active Not RecruitingNCT02567435What this trial is testingCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaWho this might be right forAlveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+3 more National Cancer Institute (NCI) 325
Testing effectiveness (Phase 2)WithdrawnNCT04906876What this trial is testing9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasWho this might be right forSarcomaSoft Tissue SarcomaMetastatic Sarcoma+10 more Brown University
Testing effectiveness (Phase 2)Study completedNCT00821249What this trial is testingARRY-520 in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple MyelomaPlasma Cell Leukemia Pfizer 55
Testing effectiveness (Phase 2)Study completedNCT00949325What this trial is testingSafety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent SarcomaWho this might be right forSarcoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)WithdrawnNCT05116800What this trial is testingPhase 2 Study of 9-ING-41 With Chemotherapy in SarcomaWho this might be right forSoft Tissue SarcomaUndifferentiated Pleomorphic SarcomaMyxofibrosarcoma+10 more Brown University
Testing effectiveness (Phase 2)Study completedNCT01962103What this trial is testingStudy to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsWho this might be right forNeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more Celgene 107